Divalproex Sodium Tablet, Film Coated, Extended Release
Product Images NDC 68084-415

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 68084-415). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

250 mg Blister

Multiple identical labels for Divalproex Sodium 250 mg extended-release tablets. Each label states the product name, dosage form as film-coated extended-release tablet, strength of 250 mg, and specifies once-daily dosing. The label includes a lot and expiry date area, a barcode, and the manufacturer American Health Packaging, Columbus, Ohio.*

FDA Label Image

250 mg Carton

Label for Divalproex Sodium extended-release tablets, USP, 250 mg strength. The label states once-daily dosing and contains 100 tablets (10 x 10). It includes handling instructions, storage conditions, and the labeler American Health Packaging in Columbus, Ohio. The label features a barcode and notes the product is Rx only.*

FDA Label Image

500 mg Blister

Divalproex Sodium 500 mg extended-release film-coated tablets packaging labels. Each label displays the product name, strength, dosage form as extended-release tablets, manufacturer American Health Packaging, UPC barcode, lot number, and expiration date. Designed for oral administration as a once-daily dose. The labels are arranged in a sheet format.*

FDA Label Image

500 mg Carton

Divalproex Sodium 500 mg extended-release film-coated tablets package label showing a 100 count (10 x 10) bottle. The label indicates once-daily dosing, the strength as 500 mg based on valproic acid activity, and the product is for oral use. It is labeled for prescription use only and distributed by American Health Packaging, Columbus, Ohio. Additional storage and safety instructions are included.*

FDA Label Image

Ahp041501

Divalproex Sodium 250 mg or 500 mg extended-release film-coated tablet, oval white, imprinted with 'ZA48' on one side; the other side is plain. Manufactured by American Health Packaging for oral administration.*

FDA Label Image

Ahp31001

Divalproex Sodium 250 mg or 500 mg extended-release film-coated oral tablets from American Health Packaging. The image shows an oblong white tablet with the imprint 'ZA47' on one side and plain on the other side.*

FDA Label Image

Figure 1

A line graph comparing the percentage reduction in CPS rate between Divalproex Sodium delayed-release tablets and placebo. The x-axis represents the percentage of patients, and the y-axis shows the percentage reduction in CPS rate, indicating improvement above zero and worsening below zero. The solid line represents Divalproex Sodium delayed-release tablets, and the dashed line represents placebo.*

FDA Label Image

Figure 2

A cumulative distribution plot showing the percent reduction in CPS rate versus the percent of patients for high dose and low dose Divalproex Sodium delayed-release tablets. The y-axis ranges from -100% (worsening) to 100% (improvement), with a zero line indicating no change. The x-axis represents percent of patients from 0 to 100%. Two lines, one solid for high dose and one dashed for low dose, track patient response.*

FDA Label Image

Figure 3

A bar chart comparing two groups: Placebo and Divalproex Sodium Extended-release Tablets. The chart shows a higher value for the Divalproex Sodium group (1.2) compared to the Placebo group (0.6), with a noted p-value of 0.006 indicating statistical significance.*

FDA Label Image

Structure

Chemical structure diagram of divalproex sodium, showing its molecular composition and arrangement of atoms.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.